chemotherapy drugs Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (2)

Phase 1 (1)
Phase 2 (1)

Interventional (2)

Baylor College of Medicine (1)
M.D. Anderson Cancer Center (1)

No (2)

No (2)

Adult (18+) (2)
Pediatric (Under 18) (1)

I am/have/had

I am/have/hadrecurrent chronic myelomonocytic leukemia

I am/have/hadrefractory chronic myelomonocytic leukemia

I am/have/hadflow cytometry

I am/have/hadserum bilirubin

I am/have/hadimmunohistochemistry

I am/have/hadBRAF

I am/have/hadacute myeloid leukemia

I am/have/hadleukemia

I am/have/hadgilbert's syndrome

I am/have/hadrefractory acute myeloid leukemia

I am/have/hadallogeneic hematopoietic stem cell transplant

I am/have/hadrefractory chronic myelomonocytic leukemia (cmml)

I am/have/hadleukemia recurrent

I am/have/hadrefractory aml

I am/have/hadmyeloid leukemia

I am/have/hadhematologic malignancy

I am/have/hadkras

I am/have/hadchronic myelomonocytic leukemia (cmml)

I am/have/hadhemolysis

I am/have/hadpulse oximetry

added new label for I am/have/had

I am looking for

I am looking forazacitidine

I am looking forchemotherapy drugs

I am looking forvenetoclax

I am looking forkras

I am looking fortrametinib

added new label for I am looking for

Advanced Filters

Found 2 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For pediatric ages
For Seniors
Recruiting in 10s
Interventional Study
all
Hematology
Recruiting

Chimeric Antigen Receptor T-cells for The Treatment of AML Expressing CLL-1 Antigen

Patients eligible for this study have a type of blood cancer Acute Myeloid Leukemia (AML) which has come back or has not gone away after treatment. The body has different ways of fighting disease and infection, and this research study combines two different ways of fighting cancer with antibodies and …

flow cytometry

apheresis

immunohistochemistry

leukemia

lymphoma

0 views
16 Feb, 2024
1 location

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Azacitidine Venetoclax and Trametinib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Higher-Risk Myelodysplastic Syndrome

This phase II trial investigates how well azacitidine, venetoclax, and trametinib work in treating patients with acute myeloid leukemia or higher-risk myelodysplastic syndrome that has come back (relapsed) or has not responded to treatment (refractory). Chemotherapy drugs, such as azacitidine, work in different ways to stop the growth of cancer …

refractory chronic myelomonocytic leukemia

recurrent chronic myelomonocytic leukemia

serum bilirubin

BRAF

acute myeloid leukemia

0 views
16 Feb, 2024
1 location